Fortress Biotech Inc (FBIO)

3.60
+0.04(+1.12%)
After Hours
3.67
+0.07(+1.944%)
- Real-time Data
  • Volume:
    680,104
  • Bid/Ask:
    3.60/3.67
  • Day's Range:
    3.55 - 3.68

FBIO Overview

Prev. Close
3.56
Day's Range
3.55-3.68
Revenue
44.27M
Open
3.58
52 wk Range
2.12-6.1
EPS
-0.57
Volume
680,104
Market Cap
350.35M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,754,006
P/E Ratio
-
Beta
2.5
1-Year Change
28.57%
Shares Outstanding
97,319,238
Next Earnings Date
Aug 12, 2021
What is your sentiment on Fortress Biotech Inc?
or
Market is currently closed. Voting is open during market hours.

Fortress Biotech Inc News

Fortress Biotech Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellStrong SellBuy
Technical IndicatorsSellBuySellStrong SellStrong Buy
SummaryStrong SellNeutralSellStrong SellStrong Buy

Fortress Biotech Inc Company Profile

Fortress Biotech Inc Company Profile

Employees
111

Fortress Biotech, Inc.(Fortress) is a biopharmaceutical company that acquires, develops and commercializes novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies. Fortress has 11 operating subsidiaries that include: 4 commercial stage programs, 25 development stage programs, targeting 6 therapeutic areas: Immuno-oncology, Hematology, Gene Therapy, Pain Management, Rare Diseases and Dermatology. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies. Fortress subsidiaries include Aevitas Therapeutics, Avenue Therapeutics, Caelum Biosciences, Cellvation, Inc., Checkpoint Therapeutics, Cyprium Therapeutics, Helocyte, Inc., Journey Medical Corporation, Mustang Bio and Tamid Bio, Inc.

Read More
  • Yeah, if money were made of thumbs you'll all be rich... FDA rejected Tramadol... good luck to you now
    0
    • yes, but we need to wait foe the right price now
      0
    • I think around 3.3 is more than fair,
      0
    • that 2.5 gap ia still there... a lot depends on the markets, but a first entrance could be made
      0
  • get out , waste of time and money
    2
    • yes , after being at 6 ... 2 months negative, but you can draw reality as it makes you feel better
      0
    • I see what i expected from this stock...huge future gain...i hold and wait!
      0
    • Ale Aleif you say so...
      0
  • good news from Mustang Bio - let's see how much they count
    0
    • at the end the wiser move was to get out... signals were pretty clear . At this point it could end up with the worst case by closing the 2.5 gap... too many uknowns. Good luck to who decided to hold this stock
      1
      • How is the q1 report? Anyone can tell us pls.
        2
        • Missed revenue and non-Gaap
          0
      • Q1 2021 results
        0
        • Great news, check company press release.
          1
          • Not about tramadol...regarding new drugs
            0
        • We'll see the bull very soon.. Look at the company and what it has.. 📈
          1
          • Here is 4 usd
            1
            • here's the $3.x again ...
              1
              • Check the best Cannbis Stock for 2021 Innocan Pharma - soon reach $1
                1
                • better stay away from this stock for a while...
                  0
                  • To investigate? Is it not a FDA problem rhat they havent answerd?
                    0
                  • Predrag Mandusicthey claim they shouldn't have communicated that
                    0
                • https://finance.yahoo.com/amphtml/news/bronstein-gewirtz-grossman-llc-notifies-183000451.html
                  0
                  • Crazy
                    0
                    • it's normal , my guess is that it will be below $4 soon
                      0
                  • Next time listen to me - why staying here ? you should have followed me on CIDM
                    1
                    • I was saying that the important thing is not us waiting but if CIPL is willing to wait
                      0
                      • I will base my operations on CIPL feedback
                        0
                      • Max Josephthey dont have choice, fda is delaying because of covid, see the J&J
                        0
                      • unfortunqtely CIPLA can decide to walk away at any time
                        0
                    • test
                      0
                      • From yahoo!I left a message to the number yesterday after reading you message. This morning i got a call from FBIO. His name was Bill. He used his personal cell to call me back. I told him on his face i am really surprise to get your call. He told me he called so many guys today who left messages. I am one of the calmn investor who left a calmn message. He told me about FDA. Per him FDA just told them they need time. FDA did not gave them any dead line of when they will get back to them. It can come any time per him. It can come in an hour or a day or a week etc. After that topic i asked him about 600K share offering. Per him this is not common share offering. The timing was really bad. He acknowledge that their stock price is falling. He and i talked for 15-20 min about company. He told me that this is not the only drug they are making. there are several other as well. He told me to patience.The guy is a long term.
                        1
                        • Still hoing up, news just came out at wallstreet journal 30 minutes ago, that fda is still reviewing, got some big exposure!
                          1
                          • I sold my shares luckily with all this craziness i made $4,020 profit.
                            0
                            • Well done! The one who listened to his own rules came out on top again
                              0
                          • First rule, invest the money you can afford to loose or wait long
                            0
                            • If you are referring to me, i can afford to lose the money I lost, but i would prefer not to ;)
                              0
                            • Not you, just a reminder for us all, poor retailers
                              0
                          • I am out guys, i think i am going to find another place to lose money. Wish you all the best!
                            0
                            • Same here!
                              0
                            • Untill fda hold the line!
                              0
                            • Good luck Predrag! I hope the patience will be rewarded
                              0
                          • FDA also pauses J&J Covid Vaccine ... thye are really getting stricter
                            0
                            • with a positive VIX and negative trends in the indexes this is not ok... In any case nor the black nor the white scenario, but the grey one happened .. too many uknowns ... what I would like to know is CIPL standpoint now... that is going to mean everything
                              0
                              • Fda postponed revision of IV tramadol, check company site now, press release!
                                1
                                • ma questo sito che problemi ha che cancella commenti a paicimento nel giro di 2 secondi ?
                                  0
                                • Censura, avviene Sempre al momento giusto
                                  0
                                • ho capito ma ho solo pubblicato quello che era stato dichiarato ufficialmente .... bah!
                                  0
                              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.